SC
IDXX icon

Solstein Capital’s Idexx Laboratories IDXX Stock Holding History

Solstein Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.99K Hold
16
– – ﹤0.01% 340
2025
Q4 		$10.8K Hold
16
– – ﹤0.01% 324
2025
Q3 		$10.2K Hold
16
– – ﹤0.01% 330
2025
Q2 		$8.58K Buy
+16
New +$7.65K ﹤0.01% 349
2020
Q2 		– Sell
-7
Closed -$2K – 261
2020
Q1 		$2K Buy
+7
New +$1.83K 0.01% 231

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Solstein Capital's IDXX Position: Q1 2026 in Review

Solstein Capital held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 16 shares worth $8.99K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Solstein Capital first reported a position in IDXX in Q1 2020 and has held it in 5 quarters since. The position peaked at $10.8K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Solstein Capital held 16 shares of Idexx Laboratories worth $8.99K as of Q1 2026.
  • Solstein Capital left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Solstein Capital's portfolio in Q1 2026, its #340 holding.
  • Solstein Capital first reported a position in Idexx Laboratories in Q1 2020 and has held it in 5 quarters since.
  • Solstein Capital's Idexx Laboratories position peaked at $10.8K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.